Patents by Inventor Devon R. Byrd

Devon R. Byrd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8030066
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites and/or multiple topoisomerase recognition sites. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: October 4, 2011
    Assignee: Life Technologies Corporation
    Inventors: Jonathan D. Chesnut, John Carrino, Louis Leong, Knut Madden, Martin Gleeson, James Fan, Michael Brasch, David Cheo, James L. Hartley, Devon R. Byrd, Gray F. Temple
  • Patent number: 6905837
    Abstract: A method is provided for identifying a restriction endonuclease, which includes the steps of (a) screening a target DNA sequence for the presence of known methylase sequence motifs, (b) identifying any open reading frames which lie close to the methylase sequence motifs screened in step (a), and (c) assaying the protein products of these open reading frames for restriction endonuclease activity. Methods for identifying isoschizomers of known restriction endonucleases, which isoschizomers possess a desired physical property, such as thermostability, are also provided by the present invention, as are several novel restriction endonucleases isolated from M. jannaschii, MjaIII and MjaIV. Additionally, a gene was identified that encoded a previously observed endonuclease activity, designated MjaII. Also provided by the present invention are vectors suitable for cloning a DNA sequence encoding a cytotoxic protein, via independent transcription promotors which may be selectively controlled by several conditions.
    Type: Grant
    Filed: July 30, 2002
    Date of Patent: June 14, 2005
    Assignee: New England Biolabs, Inc.
    Inventors: Richard J. Roberts, Devon R. Byrd, Richard D. Morgan, Jay Patti, Christopher J. Noren
  • Publication number: 20040137576
    Abstract: A method is provided for identifying a restriction endonuclease that includes: screening a target DNA sequence for the presence of known methylase sequence motifs, identifying any open reading frames which lie close to the screened methylase sequence motif and assaying the protein products of the open reading frames for restriction endonuclease activity.
    Type: Application
    Filed: February 9, 2004
    Publication date: July 15, 2004
    Inventors: Richard J. Roberts, Devon R. Byrd, Richard D. Morgan, Jay Patti, Christopher J. Noren
  • Patent number: 6689573
    Abstract: A method is provided for identifying a restriction endonuclease that includes: screening a target DNA sequence for the presence of known methylase sequence motifs, identifying any open reading frames which lie close to the screened methylase sequence motif and assaying the protein products of the open reading frames for restriction endonuclease activity.
    Type: Grant
    Filed: May 24, 2000
    Date of Patent: February 10, 2004
    Assignee: New England Biolabs, Inc.
    Inventors: Richard J. Roberts, Devon R. Byrd, Richard D. Morgan, Jay Patti, Christopher J. Noren
  • Publication number: 20030119027
    Abstract: A method is provided for identifying a restriction endonuclease, which includes the steps of (a) screening a target DNA sequence for the presence of known methylase sequence motifs, (b) identifying any open reading frames which lie close to the methylase sequence motifs screened in step (a), and (c) assaying the protein products of these open reading frames for restriction endonuclease activity.
    Type: Application
    Filed: July 30, 2002
    Publication date: June 26, 2003
    Applicant: New England Biolabs, Inc.
    Inventors: Richard J. Roberts, Devon R. Byrd, Richard D. Morgan, Jay Patti, Christopher J. Noren
  • Publication number: 20030017453
    Abstract: A method is provided for identifying a restriction endonuclease, which includes the steps of (a) screening a target DNA sequence for the presence of known methylase sequence motifs, (b) identifying any open reading frames which lie close to the methylase sequence motifs screened in step (a), and (c) assaying the protein products of these open reading frames for restriction endonuclease activity. Methods for identifying isoschizomers of known restriction endonucleases, which isoschizomers possess a desired physical property, such as thermostability, are also provided by the present invention, as are several novel restriction endonucleases isolated from M. jannaschii, MjaIII and MjaIV. Additionally, a gene was identified that encoded a previously observed endonuclease activity, designated MjaII. Also provided by the present invention are vectors suitable for cloning a DNA sequence encoding a cytotoxic protein, via independent transcription promotors which may be selectively controlled by several conditions.
    Type: Application
    Filed: January 19, 2001
    Publication date: January 23, 2003
    Inventors: Richard J. Roberts, Devon R. Byrd, Richard D. Morgan, Jay Patti, Christopher J. Noren
  • Patent number: 6383770
    Abstract: A method is provided for identifying a restriction endonuclease, which includes the steps of (a) screening a target DNA sequence for the presence of known methylase sequence motifs, (b) identifying any open reading frames which lie close to the methylase sequence motifs screened in step (a), and (c) assaying the protein products of these open reading frames for restriction endonuclease activity. Methods for identifying isoschizomers of known restriction endonucleases, which isoschizomers possess a desired physical property, such as thermostability, are also provided by the present invention, as are several novel restriction endonucleases isolated from M. jannaschii, MjaIII and MjaIV. Additionally, a gene was identified that encoded a previously observed endonuclease activity, designated MjaII. Also provided by the present invention are vectors suitable for cloning a DNA sequence encoding a cytotoxic protein, via independent transcription promotors which may be selectively controlled by several conditions.
    Type: Grant
    Filed: February 25, 2000
    Date of Patent: May 7, 2002
    Assignee: New England Biolabs, Inc.
    Inventors: Richard J. Roberts, Devon R. Byrd, Richard D. Morgan, Jay Patti, Christopher J. Noren